Table 2.
Adverse reactions reported by 4% or more of patients treated with terlipressin.
Adverse Event | Placebo % | Terlipressin % |
---|---|---|
Abdominal pain | 6.1 | 19.5 |
Nausea | 10.1 | 16.0 |
Respiratory failure | 7.1 | 15.5 |
Diarrhea | 7.1 | 13.0 |
Dyspnea | 5.1 | 12.5 |
Fluid overload | 3.0 | 8.5 |
Pleural effusion | 0 | 5.5 |
Sepsis | 1.0 | 5.5 |
Bradycardia | 0 | 5.0 |
Ischemia-related events (skin discoloration, cyanosis, ischemia, and intestinal ischemia) | 0 | 4.5 |